# Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)

> **NCT04080245** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 10 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** Treatment Group Live Attenuated Flu Vaccine (LAIV)

## Key facts

- **NCT ID:** NCT04080245
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-15
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080245, "Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04080245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*